Acute Lymphoblastic Leukemia Clinical Trials in Charlotte, North Carolina

3 studies are recruiting for acute lymphoblastic leukemia in Charlotte, North Carolina right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after treatment or is difficult to treat may provide informat…

    Stage
    Phase 1
    Ages
    Up to 22
    Site
    Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina
    Locations
    184 in total
    Run by
    PedAL BCU, LLC

    See if you can join NCT04726241 on ClinicalTrials.gov

  2. Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

    This is a Phase II clinical trial testing the use of two antigen-directed therapies, inotuzumab and blinatumomab, as part of induction therapy for children and young adults with newly diagnosed B-cell precursor acute lymphoblastic leukemia and lymphoma. Primary Objective * To assess if the flow-cyt…

    Stage
    Phase 2
    Ages
    1 to 18
    Site
    Novant Health Presbyterian Hemby Children's Hospital, Charlotte, North Carolina
    Locations
    3 in total
    Run by
    St. Jude Children's Research Hospital

    See if you can join NCT06533748 on ClinicalTrials.gov

  3. Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

    The goal of this study is to provide sufficient therapy during the time a patients' B-cell Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy) risk category is being determined. The term "risk" refers to the chance of the ALL or LLy coming back after treatment. Primary Objectives * T…

    Stage
    Phase 4
    Ages
    1 to 18
    Site
    Novant Health Presbyterian Hemby Children's Hospital, Charlotte, North Carolina
    Locations
    5 in total
    Run by
    St. Jude Children's Research Hospital

    See if you can join NCT06289673 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.